Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -14.057% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) COc1ccc(NC(=O)C2CCCN(S(=O)(=O)c3ccc4c(c3)oc(=O)n4C)C2)c(OC)c1
b) C=CCNc1nc(N2CCOCC2)c(C#N)c2c1CN(C)CC2
Answer: b. C=CCNc1nc(N2CCOCC2)c(C#N)c2c1CN(C)CC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCNc1nc(N2CCOCC2)c(C#N)c2c1CN(C)CC2
C=CCNc1nc(N2CCOCC2)c(C#N)c2c1CN(C)CC2
7-methyl-3-morpholin-4-yl-1-(prop-2-enylamino)-6,8-dihydro-5H-2,7-naphthyridine-4-carbonitrile